-
EP3356349
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3356349
| EP3356349 - INHIBITORS OF KRAS G12C MUTANT PROTEINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.03.2023 Database last updated on 02.11.2024 | |
| Former | Grant of patent is intended Status updated on 28.06.2022 | ||
| Former | Examination is in progress Status updated on 10.05.2022 | ||
| Former | Grant of patent is intended Status updated on 23.09.2021 | ||
| Former | Examination is in progress Status updated on 04.09.2020 | ||
| Former | Request for examination was made Status updated on 06.07.2018 | ||
| Former | The international publication has been made Status updated on 08.04.2017 | ||
| Former | unknown Status updated on 16.12.2016 | Most recent event Tooltip | 17.03.2023 | Application deemed to be withdrawn | published on 19.04.2023 [2023/16] | Applicant(s) | For all designated states Araxes Pharma LLC 3033 Science Park Road, Suite 220 San Diego, CA 92121 / US | [2018/32] | Inventor(s) | 01 /
LI, Liansheng 13569 Arroyo Dale Lane San Diego, California 92130 / US | 02 /
FENG, Jun 6160 Quail Run Street San Diego, California 92130 / US | 03 /
LONG, Yun, Oliver 10763 Santa Tomasa Avenue San Diego, California 92127 / US | 04 /
LIU, Yuan 3871 Camino Lindo San Diego, California 92122 / US | 05 /
REN, Pingda 5534 Havenridge Way San Diego, California 92130 / US | 06 /
LIU, Yi 4841 Barlows Landing Cove San Diego, California 92130 / US | [2018/32] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2018/32] | Application number, filing date | 16778628.4 | 28.09.2016 | [2018/32] | WO2016US54179 | Priority number, date | US201562233814P | 28.09.2015 Original published format: US 201562233814 P | US201662342040P | 26.05.2016 Original published format: US 201662342040 P | [2018/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017058915 | Date: | 06.04.2017 | Language: | EN | [2017/14] | Type: | A1 Application with search report | No.: | EP3356349 | Date: | 08.08.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.04.2017 takes the place of the publication of the European patent application. | [2018/32] | Search report(s) | International search report - published on: | EP | 06.04.2017 | Classification | IPC: | C07D403/04, C07D403/14, C07D413/04, C07D417/04, C07D243/14, C07D471/04, C07D307/82, A61K31/4355, A61K31/428, A61P35/00 | [2018/32] | CPC: |
C07D471/04 (EP,US);
A61P35/00 (EP);
C07D243/14 (EP,US);
C07D307/82 (EP,US);
C07D403/04 (EP,US);
C07D403/14 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/32] | Title | German: | INHIBITOREN VON KRAS G12C MUTANTEN PROTEINEN | [2021/40] | English: | INHIBITORS OF KRAS G12C MUTANT PROTEINS | [2018/32] | French: | INHIBITEURS DES PROTEINES MUTANTES KRAS G12C | [2021/40] |
| Former [2018/32] | INHIBITOREN VON KRAS-G12C-MUTANTEN PROTEINEN | ||
| Former [2018/32] | INHIBITEURS DE PROTÉINES MUTANTES KRAS G12C | Entry into regional phase | 23.04.2018 | National basic fee paid | 23.04.2018 | Designation fee(s) paid | 23.04.2018 | Examination fee paid | Examination procedure | 23.04.2018 | Examination requested [2018/32] | 23.04.2018 | Date on which the examining division has become responsible | 07.12.2018 | Amendment by applicant (claims and/or description) | 08.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 18.01.2021 | Reply to a communication from the examining division | 11.06.2021 | Despatch of a communication from the examining division (Time limit: M02) | 23.08.2021 | Reply to a communication from the examining division | 24.09.2021 | Communication of intention to grant the patent | 10.05.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.06.2022 | Communication of intention to grant the patent | 10.11.2022 | Application deemed to be withdrawn, date of legal effect [2023/16] | 30.11.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2023/16] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 10.05.2022 | Request for further processing filed | 10.05.2022 | Full payment received (date of receipt of payment) Request granted | 20.05.2022 | Decision despatched | Fees paid | Renewal fee | 27.09.2018 | Renewal fee patent year 03 | 27.09.2019 | Renewal fee patent year 04 | 14.09.2020 | Renewal fee patent year 05 | 11.09.2021 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.09.2022 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]JP2007016011 (NIPPON SODA CO) [X] 1,2,7,9,17,18,43-45,47-49 * page 31 (structure of h1) and last examples of pages 33, 35, 37, 39, 41, 43 *; | [X]WO2007113226 (NOVARTIS AG [CH], et al) [X] 1-6,17,18,35,43,45,47-49 * claims 1, 24-25, 50, 66; compound 40k *; | [X]US2013029964 (AOKI KAZUMASA [JP], et al) [X] 1,5,7,9,11-15,17,43,44,47-49 * e.g. examples 17, 76 and 104;; claims 1, 3, 11 *; | [X]WO2015054572 (ARAXES PHARMA LLC [US], et al) [X] 1-61 * the whole document *; | [AP]WO2016049524 (ARAXES PHARMA LLC [US]) [AP] 1-61* claims 1, 46-60 * |